NeuroPace, Inc.
NPCE
$14.09
-$0.03-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.47M | -23.99M | -25.94M | -24.81M | -27.14M |
| Total Depreciation and Amortization | 1.95M | 1.88M | 1.84M | 1.81M | 1.77M |
| Total Amortization of Deferred Charges | 237.00K | 223.00K | 200.00K | 199.00K | 228.00K |
| Total Other Non-Cash Items | 12.29M | 12.53M | 12.54M | 12.07M | 12.65M |
| Change in Net Operating Assets | -4.01M | -6.95M | -4.73M | -7.18M | -5.45M |
| Cash from Operations | -11.01M | -16.31M | -16.09M | -17.90M | -17.95M |
| Capital Expenditure | -332.00K | -274.00K | -344.00K | -239.00K | -306.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 2.00M | 3.50M | 6.80M | 9.30M |
| Cash from Investing | -332.00K | 1.73M | 3.16M | 6.56M | 8.99M |
| Total Debt Issued | 58.44M | 58.44M | 58.57M | -- | -- |
| Total Debt Repaid | -60.51M | -60.51M | -60.51M | -- | -- |
| Issuance of Common Stock | 71.81M | 72.03M | 74.99M | 75.37M | 5.21M |
| Repurchase of Common Stock | -50.14M | -50.14M | -50.11M | -50.01M | -881.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19.60M | 19.81M | 22.95M | 25.36M | 4.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.26M | 5.23M | 10.01M | 14.02M | -4.63M |